A Message from the President

Thank you for visiting the Global Allergy and Airways Patient Platform website. On behalf of the members of GAAPP and its Executive body, I welcome you and invite you to explore this website, become more familiar with our network, and share your ideas and concerns with us.

In 2009, patient groups gathered in Buenos Aires, Argentina, to establish GAAPP as a network linking organizations with a common interest: to support and improve the quality of life of people around the globe who have allergies and asthma. Since then we have grown into a vibrant worldwide organization with more than 100 constituent members from every continent sharing information, best practices, concerns, and hopes.

While based in Vienna, Austria, our Board is representative of diverse regions of the world, both large and small groups, all with a common purpose: empowering patients and raising the collective patient voice so decision-makers in the public and private sectors, in government and industry, will be mindful of patients’ needs, desires, and rights.

While patient-focused, we work in concert with healthcare professionals, researchers and scientists, industry, and governments to further the care of people with atopic and airways diseases. We acknowledge profound regional differences and work to support the aspirations of all patients regardless of where they live.

Our goal is to help patients and their families throughout their healthcare journey. Equally, we raise issues of concern to patients with national and international decision-makers. We are a forum to share program and policy ideas.

I invite you to explore these pages and our links to various international partners. We value your ideas and expressions of support, including financial support, as we work to increase public awareness of these diseases and improve the lives of those affected by them.

The importance of listening to the patient’s voice is critical, and now it will be heard more than ever as we serve on WHO GARD, GINA, GOLD and publish peer-reviewed articles from the patient’s perspective.

Please do not hesitate to contact us with either questions or suggestions.


Tonya Winders
President & CEO, Global Allergy & Airways Patient Platform

Meet the GAAPP Board of Directors

Tonya A. Winders

President & CEO
United States of America


Kristine Whorlow AM

Vice President

Migdalia Denis

United States of America

Dr. Ashok Gupta


Ugochukwu Nwangoro


Dr. Vũ Trần Thiên Quân 


Chief Scientific Officer

Ruth Tal Singer

Chief Scientific Officer
United States of America

Executive Team

Víctor Gascón Moreno

VP of Awareness and Operations

Kristen Willard

VP of Education
United States of America

Špela Novak

Member Support

Note on translation: This page translation has been reviewed by a native language speaker in German and Spanish. All other languages have been auto-translated from English.